A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
Trial · NCT01644500
Results by group180
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 180
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in HbA1c at 26 Weeks | 1.5 mg Dulaglutide | -1.48 | Standard Error 0.069 | percentage of HbA1c | |
| Change From Baseline in HbA1c at 26 Weeks | 0.75 mg Dulaglutide | -1.22 | Standard Error 0.069 | percentage of HbA1c | |
| Change From Baseline in HbA1c at 26 Weeks | Glimepiride | -0.92 | Standard Error 0.069 | percentage of HbA1c | |
| Percentage of Participants Attaining HbA1c of <7% or ≤6.5% at 26 Weeks | 1.5 mg Dulaglutide | HbA1c ≤6.5% | 59.4 | percentage of participants | |
| Percentage of Participants Attaining HbA1c of <7% or ≤6.5% at 26 Weeks | 0.75 mg Dulaglutide | HbA1c ≤6.5% | 47.7 | percentage of participants | |
| Percentage of Participants Attaining HbA1c of <7% or ≤6.5% at 26 Weeks | Glimepiride | HbA1c ≤6.5% | 41.3 | percentage of participants | |
| Percentage of Participants Attaining HbA1c of <7% or ≤6.5% at 26 Weeks | 1.5 mg Dulaglutide | HbA1c <7.0% | 74.1 | percentage of participants | |
| Percentage of Participants Attaining HbA1c of <7% or ≤6.5% at 26 Weeks | 0.75 mg Dulaglutide | HbA1c <7.0% | 63.6 | percentage of participants | |
| Percentage of Participants Attaining HbA1c of <7% or ≤6.5% at 26 Weeks | Glimepiride | HbA1c <7.0% | 57.4 | percentage of participants | |
| Change From Baseline in Fasting Blood Glucose (FBG) at 26 Weeks | 1.5 mg Dulaglutide | -2.71 | Standard Error 0.135 | millimoles per liter (mmol/L) | |
| Change From Baseline in Fasting Blood Glucose (FBG) at 26 Weeks | 0.75 mg Dulaglutide | -2.26 | Standard Error 0.137 | millimoles per liter (mmol/L) | |
| Change From Baseline in Fasting Blood Glucose (FBG) at 26 Weeks | Glimepiride | -1.89 | Standard Error 0.136 | millimoles per liter (mmol/L) | |
| Change From Baseline in 7-point Self-monitored Blood Glucose (SMBG) Profiles at 26 Weeks | 1.5 mg Dulaglutide | Morning (fasting) | -2.47 | Standard Error 0.092 | mmol/L |
| Change From Baseline in 7-point Self-monitored Blood Glucose (SMBG) Profiles at 26 Weeks | 0.75 mg Dulaglutide | Morning (fasting) | -1.91 | Standard Error 0.092 | mmol/L |
| Change From Baseline in 7-point Self-monitored Blood Glucose (SMBG) Profiles at 26 Weeks | Glimepiride | Morning (fasting) | -1.80 | Standard Error 0.091 | mmol/L |
| Change From Baseline in 7-point Self-monitored Blood Glucose (SMBG) Profiles at 26 Weeks | 1.5 mg Dulaglutide | Morning (2 hours post-prandial) meal | -4.56 | Standard Error 0.180 | mmol/L |
| Change From Baseline in 7-point Self-monitored Blood Glucose (SMBG) Profiles at 26 Weeks | 0.75 mg Dulaglutide | Morning (2 hours post-prandial) meal | -3.75 | Standard Error 0.181 | mmol/L |
| Change From Baseline in 7-point Self-monitored Blood Glucose (SMBG) Profiles at 26 Weeks | Glimepiride | Morning (2 hours post-prandial) meal | -3.20 | Standard Error 0.179 | mmol/L |
| Change From Baseline in 7-point Self-monitored Blood Glucose (SMBG) Profiles at 26 Weeks | 1.5 mg Dulaglutide | Midday (pre-prandial) meal | -3.09 | Standard Error 0.151 | mmol/L |
| Change From Baseline in 7-point Self-monitored Blood Glucose (SMBG) Profiles at 26 Weeks | 0.75 mg Dulaglutide | Midday (pre-prandial) meal | -2.43 | Standard Error 0.151 | mmol/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01644500/results